title: Antiretroviral and anti-hepatitis C virus direct-acting antiviral-related hepatotoxicity.
abstract: Antiretroviral-related hepatotoxicity occurs commonly in patients with human immunodeficiency virus (HIV). Liver injury ranges from unconjugated hyperbilirubinemia and nodular regenerative hyperplasia to lactic acidosis and toxic hepatitis. Effective antiretroviral therapy has changed coinfected patients' primary morbidities and mortality to chronic liver disease rather than complications from HIV. Treatment for hepatitis C virus (HCV) is strongly encouraged early in all coinfected patients. However, drug-drug interactions must be considered to ensure safe and tolerable use alone or in combination with antiretroviral therapies. The first-generation and newer HCV direct-acting antivirals are promising in coinfected patients, with minimal side effects and hepatotoxicity.
authors.affiliation: Department of Medicine, Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, 1468 Madison Avenue, Annenberg 21-42, New York, NY 10029, USA.
authors.forename: Hyosun
authors.initials: H
authors.lastname: Han
authors.forename: Ritu
authors.initials: R
authors.lastname: Agarwal
authors.forename: Valerie
authors.initials: V
authors.lastname: Martel-Laferriere
authors.forename: Douglas T
authors.initials: DT
authors.lastname: Dieterich
mesh_terms: D044966:Anti-Retroviral Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D006678:HIV; D015658:HIV Infections / Q000188:drug therapy; D016174:Hepacivirus / Q000187:drug effects*; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans
chemical_list: D044966:Anti-Retroviral Agents; D000998:Antiviral Agents
keywords: ARV; Coinfection; DAAs; Drug-induced liver injury; HCV; HIV; Hepatotoxicity